A 14 ‐Protein Signature for Rapid Identification of Poor Prognosis Stage III Metastatic Melanoma

PROTEOMICS – Clinical Applications,Volume 12, Issue 3, May 2018.
Source: Proteomics. Clinical Applications - Category: Biochemistry Authors: Source Type: research